Ketorolac ophthalmic - AbbVie
At a glance
- Drug Originator Roche Palo Alto LLC
- Drug Licenced by AbbVie
- Drug Class 2 ring heterocyclic compounds; Carboxylic acids; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrroles; Small molecules
- Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors
- USA Patent Applicants ABBVIE
- USA Patents 25
- NDAs 2
- International Patents 68
- Patent Applications 9,530
Disclaimer